<VariationArchive VariationID="840232" VariationName="NM_001243279.3(ACSF3):c.1602dup (p.Glu535fs)" VariationType="Duplication" Accession="VCV000840232" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="844489" VariationID="840232">
      <GeneList>
        <Gene Symbol="ACSF3" FullName="acyl-CoA synthetase family member 3" GeneID="197322" HGNC_ID="HGNC:27288" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89093852" stop="89156233" display_start="89093852" display_stop="89156233" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89160216" stop="89222170" display_start="89160216" display_stop="89222170" Strand="+" />
          </Location>
          <OMIM>614245</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001243279.3(ACSF3):c.1602dup (p.Glu535fs)</Name>
      <CanonicalSPDI>NC_000016.10:89146035:AAA:AAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89146035" stop="89146036" display_start="89146035" display_stop="89146036" variantLength="1" positionVCF="89146035" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89212443" stop="89212444" display_start="89212443" display_stop="89212444" variantLength="1" positionVCF="89212443" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>E270fs</ProteinChange>
      <ProteinChange>E535fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.89146038dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.89146038dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.89212446dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.89212446dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031961.1" sequenceAccession="NG_031961" sequenceVersion="1" change="g.57230dup">
            <Expression>NG_031961.1:g.57230dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127214.4" sequenceAccession="NM_001127214" sequenceVersion="4" change="c.1602dup">
            <Expression>NM_001127214.4:c.1602dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120686.1" sequenceAccession="NP_001120686" sequenceVersion="1" change="p.Glu535fs">
            <Expression>NP_001120686.1:p.Glu535fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001243279.3" sequenceAccession="NM_001243279" sequenceVersion="3" change="c.1602dup" MANESelect="true">
            <Expression>NM_001243279.3:c.1602dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001230208.1" sequenceAccession="NP_001230208" sequenceVersion="1" change="p.Glu535fs">
            <Expression>NP_001230208.1:p.Glu535fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001284316.2" sequenceAccession="NM_001284316" sequenceVersion="2" change="c.807dup">
            <Expression>NM_001284316.2:c.807dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001271245.1" sequenceAccession="NP_001271245" sequenceVersion="1" change="p.Glu270fs">
            <Expression>NP_001271245.1:p.Glu270fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_174917.5" sequenceAccession="NM_174917" sequenceVersion="5" change="c.1602dup">
            <Expression>NM_174917.5:c.1602dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_777577.2" sequenceAccession="NP_777577" sequenceVersion="2" change="p.Glu535fs">
            <Expression>NP_777577.2:p.Glu535fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_045667.2" sequenceAccession="NR_045667" sequenceVersion="2" change="n.728dup">
            <Expression>NR_045667.2:n.728dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_104293.2" sequenceAccession="NR_104293" sequenceVersion="2" change="n.1993dup">
            <Expression>NR_104293.2:n.1993dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147928.2" sequenceAccession="NR_147928" sequenceVersion="2" change="n.2037dup">
            <Expression>NR_147928.2:n.2037dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147929.2" sequenceAccession="NR_147929" sequenceVersion="2" change="n.1791dup">
            <Expression>NR_147929.2:n.1791dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1350227206" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001243279.3(ACSF3):c.1602dup (p.Glu535fs) AND Combined malonic and methylmalonic acidemia" Accession="RCV001042177" Version="7">
        <ClassifiedConditionList TraitSetID="7620">
          <ClassifiedCondition DB="MedGen" ID="C3280314">Combined malonic and methylmalonic acidemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7620" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16574" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Combined malonic and methylmalonic acidemia</ElementValue>
                <XRef ID="MONDO:0013661" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Combined malonic and methylmalonic aciduria</ElementValue>
                <XRef ID="Combined+malonic+and+methylmalonic+aciduria/8011" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMAMMA</ElementValue>
                <XRef Type="MIM" ID="614265" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10818" />
                <XRef ID="10818" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="289504" DB="Orphanet" />
              <XRef ID="C3280314" DB="MedGen" />
              <XRef ID="MONDO:0013661" DB="MONDO" />
              <XRef Type="MIM" ID="614265" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2371082" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="8812588|MedGen:C3280314" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001205844" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ACSF3 protein in which other variant(s) (p.Glu549*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 840232). This variant has not been reported in the literature in individuals affected with ACSF3-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Glu535Argfs*31) in the ACSF3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 42 amino acid(s) of the ACSF3 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACSF3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.89212443_89212444insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280314" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2371082" TraitType="Disease" MappingType="XRef" MappingValue="C3280314" MappingRef="MedGen">
        <MedGen CUI="C3280314" Name="Combined malonic and methylmalonic acidemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

